KRAS mutations are common in ampullary cancer although the 25 to 37% incidence appears to be lower than the approximately 95% rate of KRAS mutation seen in pancreatic adenocarcinomas [13,14,22,23]. Here, KRAS is linked to carcinoma of the ampulla of vater.